aphranel

我们的解决方案

Aphranel® MagiCCrystal Novo

Precision Structural Support. Regeneration Over Time.

Modern aesthetic medicine is no longer defined by immediate transformation alone. Increasingly, both patients and physicians are seeking regenerative solutions that respect individuality, support natural aging, and deliver results that evolve gracefully over time.


Aphranel® MagiCCrystal Novo is a regenerative CaHA (Calcium Hydroxyapatite)-based injectable filler designed for structural support, contour enhancement, and collagen regeneration. Developed with a dual-regeneration mechanism and a structural system composed of 30% CaHA microspheres and 70% CMC gel carrier, it provides immediate structural support while supporting progressive collagen regeneration.


As structure and regeneration work together over time, Aphranel® helps create aesthetic outcomes that are balanced, natural-looking, and enduring.

优法兰 MagiCCrystal Novo 再生美学三维体系:即刻塑形、渐进再生、可控降解 — 美存于时间,塑形·再生·蜕变

Composition

Dual-Regeneration Structural System: Developed with a dual-regeneration mechanism and a structural system composed of 30% CaHA microspheres and 70% CMC gel carrier, Aphranel® MagiCCrystal Novo provides immediate structural support while supporting progressive collagen regeneration.


Over time, structural refinement and natural collagen regeneration work in harmony, delivering aesthetic outcomes that are balanced, natural-looking, and long-lasting.


30% CaHA Microspheres:Designed to provide structural support and biostimulatory activity, the CaHA microspheres are engineered with a controlled particle size distribution of approximately 30–35 μm, supporting tissue integration and collagen regeneration.


70% CMC Gel Carrier:Acts as a carrier matrix to ensure smooth injectability, uniform microsphere distribution, and stable product placement, while supporting controlled biodegradation over time.

优法兰 MagiCCrystal Novo 双再生结构体系:30% CaHA微球 + 70% CMC凝胶载体组成示意图

Core Technologies

ACD-MT® PATENTED MICROSPHERE TECHNOLOGY:

Accurate Controllable Degradation

Microsphere Technology

ACD-MT专利微球技术概览:均匀粒径30至35微米、大比表面积促进成纤维细胞生长、树莓状表面增强细胞黏附、通孔结构精确控制降解速率

PCD-ETT® PATENTED CMC GEL TECHNOLOGY:

Physical Crosslinking Dynamic

Entanglement Topology Technology

PCD-ETT CMC凝胶技术:无化学交联剂,渐进降解无残留物质
PCD-ETT CMC凝胶技术:微球均匀分布,支持平滑注射与精准定位
PCD-ETT CMC凝胶技术:高G'值约5500帕斯卡粘弹性,提供强力结构支撑与稳定轮廓塑形
PCD-ETT CMC凝胶技术:接近人体渗透压约299毫渗摩尔每千克,减少术后肿胀提升注射舒适度
HOW IT WORKS

Mechanism of Action

Aphranel MagiCCrystal Novo 7-step mechanism of action: 1. Before Treatment with collagen and volume loss, 2. Injection of 17 million CaHA microspheres in CMC gel, 3. Immediate Structural Support from gel carrier, 4. Progressive Carrier Resorption, 5. Collagen Regeneration via fibroblast stimulation, 6. Controlled Biodegradation of microspheres, 7. Long-Term natural-looking results from regenerated collagen

Global Certifications

Aphranel MagiCCrystal Novo global certifications: China Class III Medical Device Certification, European Union MDR Certification, Saudi Arabia SFDA Certification

Case Interaction